TY  -  
T1  - Relationship between baseline physical activity assessed by pedometer count and new-onset diabetes in the NAVIGATOR trial 
SN  -  /  
UR  - http://hdl.handle.net/10138/299730 
T3  -  
A1  - Kraus, W.E.; Yates, T.; Tuomilehto, J.; Sun, J.-L.; Thomas, L.; Mcmurray, J.J.V.; Bethel, M.A.; Holman, R.R. 
A2  -  
PB  -  
Y1  - 2018 
LA  - eng 
AB  - Objective: Physical activity is related to clinical outcomes, even after adjusting for body mass, but is rarely assessed in randomized clinical trials. Research design and methods: We conducted an observational analysis of data from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial, in which a total of 9306 people from 40 countries with impaired glucose tolerance and either cardiovascular disease or cardiovascular risk factors were randomized to receive nateglin... 
VO  -  
IS  -  
SP  -  
OP  -  
KW  - nateglinide; placebo; valsartan, adult; aged; Article; body mass; cardiovascular disease; cardiovascular risk; clinical outcome; controlled study; diabetes mellitus; disease exacerbation; double blind procedure; female; follow up; human; impaired glucose tolerance; lifestyle modification; major clinical study; male; observational study; physical activity; randomized controlled trial; risk reduction; 3141 Health care science 
N1  -   
PP  -  
ER  -